Cargando…

Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation

Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in hepatocellular carcinoma (HCC). How CSCs interact with the tumor microenvironment and the adaptive immune system is unclear. Methods: We screened aggressive human HCC for macroH2A1 and CD44 CSC marker e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo Re, Oriana, Mazza, Tommaso, Giallongo, Sebastiano, Sanna, Paola, Rappa, Francesca, Vinh Luong, Tu, Li Volti, Giovanni, Drovakova, Adela, Roskams, Tania, Van Haele, Matthias, Tsochatzis, Emmanuel, Vinciguerra, Manlio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929991/
https://www.ncbi.nlm.nih.gov/pubmed/31903159
http://dx.doi.org/10.7150/thno.35045
_version_ 1783482808899993600
author Lo Re, Oriana
Mazza, Tommaso
Giallongo, Sebastiano
Sanna, Paola
Rappa, Francesca
Vinh Luong, Tu
Li Volti, Giovanni
Drovakova, Adela
Roskams, Tania
Van Haele, Matthias
Tsochatzis, Emmanuel
Vinciguerra, Manlio
author_facet Lo Re, Oriana
Mazza, Tommaso
Giallongo, Sebastiano
Sanna, Paola
Rappa, Francesca
Vinh Luong, Tu
Li Volti, Giovanni
Drovakova, Adela
Roskams, Tania
Van Haele, Matthias
Tsochatzis, Emmanuel
Vinciguerra, Manlio
author_sort Lo Re, Oriana
collection PubMed
description Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in hepatocellular carcinoma (HCC). How CSCs interact with the tumor microenvironment and the adaptive immune system is unclear. Methods: We screened aggressive human HCC for macroH2A1 and CD44 CSC marker expression. We also knocked down (KD) macroH2A1 in HCC cells, and performed integrated transcriptomic and secretomic analyses. Results: Human HCC showed low macroH2A1 and high CD44 expression compared to control tissues. MacroH2A1 KD CSC-like cells transferred paracrinally their chemoresistant properties to parental HCC cells. MacroH2A1 KD conditioned media transcriptionally reprogrammed parental HCC cells activated regulatory CD4(+)/CD25(+)/FoxP3(+) T cells (Tregs). Conclusions: Loss of macroH2A1 in HCC cells drives cancer stem-cell propagation and evasion from immune surveillance.
format Online
Article
Text
id pubmed-6929991
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-69299912020-01-04 Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation Lo Re, Oriana Mazza, Tommaso Giallongo, Sebastiano Sanna, Paola Rappa, Francesca Vinh Luong, Tu Li Volti, Giovanni Drovakova, Adela Roskams, Tania Van Haele, Matthias Tsochatzis, Emmanuel Vinciguerra, Manlio Theranostics Research Paper Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in hepatocellular carcinoma (HCC). How CSCs interact with the tumor microenvironment and the adaptive immune system is unclear. Methods: We screened aggressive human HCC for macroH2A1 and CD44 CSC marker expression. We also knocked down (KD) macroH2A1 in HCC cells, and performed integrated transcriptomic and secretomic analyses. Results: Human HCC showed low macroH2A1 and high CD44 expression compared to control tissues. MacroH2A1 KD CSC-like cells transferred paracrinally their chemoresistant properties to parental HCC cells. MacroH2A1 KD conditioned media transcriptionally reprogrammed parental HCC cells activated regulatory CD4(+)/CD25(+)/FoxP3(+) T cells (Tregs). Conclusions: Loss of macroH2A1 in HCC cells drives cancer stem-cell propagation and evasion from immune surveillance. Ivyspring International Publisher 2020-01-01 /pmc/articles/PMC6929991/ /pubmed/31903159 http://dx.doi.org/10.7150/thno.35045 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Lo Re, Oriana
Mazza, Tommaso
Giallongo, Sebastiano
Sanna, Paola
Rappa, Francesca
Vinh Luong, Tu
Li Volti, Giovanni
Drovakova, Adela
Roskams, Tania
Van Haele, Matthias
Tsochatzis, Emmanuel
Vinciguerra, Manlio
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation
title Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation
title_full Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation
title_fullStr Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation
title_full_unstemmed Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation
title_short Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation
title_sort loss of histone macroh2a1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and cd4(+)cd25(+)foxp3(+) regulatory t cells activation
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929991/
https://www.ncbi.nlm.nih.gov/pubmed/31903159
http://dx.doi.org/10.7150/thno.35045
work_keys_str_mv AT loreoriana lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT mazzatommaso lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT giallongosebastiano lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT sannapaola lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT rappafrancesca lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT vinhluongtu lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT livoltigiovanni lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT drovakovaadela lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT roskamstania lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT vanhaelematthias lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT tsochatzisemmanuel lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation
AT vinciguerramanlio lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation